- Home
- ISPO vs ARMP Comparison
ISPO vs ARMP Comparison
Compare ISPO & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPO
- ARMP
- Stock Information
- Founded
- ISPO 2010
- ARMP N/A
- Country
- ISPO United States
- ARMP United States
- Employees
- ISPO N/A
- ARMP N/A
- Industry
- ISPO Blank Checks
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ISPO Finance
- ARMP Health Care
- Exchange
- ISPO Nasdaq
- ARMP Nasdaq
- Market Cap
- ISPO 44.3M
- ARMP 52.1M
- IPO Year
- ISPO N/A
- ARMP N/A
- Fundamental
- Price
- ISPO $3.05
- ARMP $2.37
- Analyst Decision
- ISPO
- ARMP Strong Buy
- Analyst Count
- ISPO 0
- ARMP 1
- Target Price
- ISPO N/A
- ARMP $9.00
- AVG Volume (30 Days)
- ISPO 48.5K
- ARMP 18.6K
- Earning Date
- ISPO 08-12-2025
- ARMP 08-12-2025
- Dividend Yield
- ISPO N/A
- ARMP N/A
- EPS Growth
- ISPO N/A
- ARMP N/A
- EPS
- ISPO N/A
- ARMP N/A
- Revenue
- ISPO $265,499,000.00
- ARMP $4,699,000.00
- Revenue This Year
- ISPO N/A
- ARMP $8.43
- Revenue Next Year
- ISPO $148.67
- ARMP N/A
- P/E Ratio
- ISPO N/A
- ARMP N/A
- Revenue Growth
- ISPO N/A
- ARMP 14.24
- 52 Week Low
- ISPO $3.01
- ARMP $0.90
- 52 Week High
- ISPO $9.31
- ARMP $3.27
- Technical
- Relative Strength Index (RSI)
- ISPO 35.87
- ARMP 61.86
- Support Level
- ISPO $3.16
- ARMP $2.14
- Resistance Level
- ISPO $3.41
- ARMP $2.56
- Average True Range (ATR)
- ISPO 0.24
- ARMP 0.17
- MACD
- ISPO -0.06
- ARMP 0.03
- Stochastic Oscillator
- ISPO 5.63
- ARMP 73.24
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.